Review
Immunology
Paul Curtiss, Amanda M. Walker, Benjamin F. Chong
Summary: This study reviewed patient cohorts and populations to investigate the progression of cutaneous lupus to systemic lupus. The study found variations in the progression rates between adult and pediatric groups, which were attributed to differences in patient populations, study design, diagnostic criteria, and follow-up time. Risk factors associated with the development of systemic lupus included positive anti-nuclear antibodies, hematologic abnormalities, and a higher number of lupus classification criteria at baseline.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Qian Chen, Jie Wang, Mengmeng Xiang, Yilun Wang, Zhixiong Zhang, Jun Liang, Jinhua Xu
Summary: This review summarizes the potential links between ferroptosis and systemic lupus erythematosus (SLE), elucidates the role of ferroptosis in SLE pathogenesis, and proposes a new therapeutic strategy for SLE.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Oncology
Kaichi Kaneko, Hao Chen, Matthew Kaufman, Isaak Sverdlov, Emily M. Stein, Kyung-Hyun Park-Min
Summary: Osteonecrosis is a complex and devastating complication of systemic lupus erythematosus, with variable prevalence in SLE patients. The use of high-dose glucocorticoid therapy is strongly associated with the development of osteonecrosis in SLE patients, although the exact pathophysiology and risk factors for osteonecrosis in this population are not fully understood.
CLINICAL AND TRANSLATIONAL MEDICINE
(2021)
Review
Biochemistry & Molecular Biology
Valeria Rella, Cinzia Rotondo, Alberto Altomare, Francesco Paolo Cantatore, Addolorata Corrado
Summary: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations. Dysregulation of the immune system due to genetic, hormonal, and environmental factors can lead to various complications, including bone involvement such as osteoporosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Immunology
Zhou She, Cuifang Li, Feifeng Wu, Jueyi Mao, Min Xie, Marady Hun, Amin Sheikh Abdirahman, Senlin Luo, Wuqing Wan, Jidong Tian, Chuan Wen
Summary: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by multisystemic and multi-organ involvement. The role of B1 cells in SLE remains unclear, but understanding their mechanism can provide new insights into the pathogenesis and treatment of SLE.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Medicine, General & Internal
Minhui Wang, Ziqian Wang, Shangzhu Zhang, Yang Wu, Zhang Li, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng
Summary: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a disease with diverse subtypes and severities, involving ischemic and inflammatory mechanisms as well as brain-intrinsic factors. Understanding the underlying mechanisms of NPSLE may lead to new treatment options, as shown in mouse models. However, current conventional therapies are only supported by observational studies, highlighting the need for controlled clinical trials.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Clinical Neurology
Dionysis Nikolopoulos, Dimitrios Kitsos, Matilda Papathanasiou, Noemin Kapsala, Panagiotis Garantziotis, Antigone Pieta, Ourania Gioti, Alexandros Grivas, Konstantinos Voumvourakis, Dimitrios Boumpas, Antonis Fanouriakis
Summary: In a large SLE cohort, CNS demyelinating syndromes were characterized as neuropsychiatric SLE (NPSLE) or SLE-MS overlap. Patients with SLE-MS overlap had a higher likelihood of neurologic relapses, while those with SLE-demyelination were less likely to have neurological deficits at the last follow-up visit.
FRONTIERS IN NEUROLOGY
(2022)
Review
Immunology
Yaling Liu, Xinyu Tao, Jinhui Tao
Summary: This paper reviews the role of inflammasomes in the pathogenesis of SLE and their therapeutic implications. It points out that inflammasomes not only regulate the abnormal differentiation of immune cells, but also modulate the production of pathogenic autoantibodies and participate in organ damage.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Rheumatology
Alexandra Legge, Alicia Malone, John G. Hanly
Summary: The SLICC frailty index (SLICC-FI) has been validated in a prevalent cohort of individuals with longstanding SLE, showing that higher baseline SLICC-FI values are associated with increased mortality risk and damage accrual.
Article
Chemistry, Multidisciplinary
Shunxiang Li, Huihua Ding, Ziheng Qi, Jing Yang, Jingyi Huang, Lin Huang, Mengji Zhang, Yuanjia Tang, Nan Shen, Kun Qian, Qiang Guo, Jingjing Wan
Summary: Serum metabolic fingerprints can be used for disease diagnosis and biomarker discovery. By analyzing the serum metabolic fingerprints of systemic lupus erythematosus (SLE) patients and healthy controls, early diagnosis and precision medicine for SLE can be achieved. This study identified the unique metabolic pattern of SLE patients and screened out a panel of metabolic biomarkers.
Article
Immunology
Jingquan He, Chiyu Ma, Donge Tang, Shaoyun Zhong, Xiaofang Yuan, Fengping Zheng, Zhipeng Zeng, Yumei Chen, Dongzhou Liu, Xiaoping Hong, Weier Dai, Lianghong Yin, Yong Dai
Summary: This study investigated the alteration of oxylipins in the serum of systemic lupus erythematosus (SLE) patients and identified potential biomarkers for SLE classification. The results showed that certain oxylipins were correlated with lupus nephritis (LN) and SLE disease activity. Additionally, a combination of 5 oxylipins was found to have high accuracy in classifying SLE patients. The findings provide insights into the characteristics of SLE and the development of new tools for classification.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Cell Biology
Chenghui Zheng, Lin Xie, Haihong Qin, Xiao Liu, Xi Chen, Fan Lv, Li Wang, Xiaohua Zhu, Jinhua Xu
Summary: Extracellular vesicles (EVs) are small vesicles actively secreted by most cell types, which can carry various substances and play important roles in immune modulation and the pathogenesis of autoimmune diseases. This review summarizes the recent research on EVs and discusses their applications in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus (SLE).
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Review
Immunology
Swayanka Biswas, Katja Bieber, Rudolf Armin Manz
Summary: IL-10 is a cytokine that has pleiotropic effects on immune cells, including both suppressive and activating functions. It plays a dual role in Systemic lupus Erythematosus (SLE), inhibiting pro-inflammatory effector functions while also promoting extrafollicular antibody response. IL-10 is produced by B cells, myeloid cells, and certain T cell subsets, and it drives B cell responses, proliferation, class switching, and plasma cell formation.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Hongjiang Liu, Yundong Zou, Chen Chen, Yundi Tang, Jianping Guo
Summary: Systemic lupus erythematosus (SLE) is a common autoimmune disease that affects multiple organs and its pathogenesis is still unclear. Circular RNAs (circRNAs) are a novel class of non-coding RNAs with closed loop structure that may play essential roles in gene expression, cell function, and the development of autoimmune diseases, including SLE. CircRNAs exhibit tissue-specific expression patterns and have implications in immune responses and autoimmune diseases.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Cristina Cocco, Elias Manca, Giulia Corda, Maria Maddalena Angioni, Barbara Noli, Mattia Congia, Francesco Loy, Michela Isola, Elisabetta Chessa, Alberto Floris, Lorena Lorefice, Luca Saba, Alessandro Mathieu, Gian Luca Ferri, Alberto Cauli, Matteo Piga
Summary: Brain-reactive autoantibodies are found in patients with SLE and NPSLE, with higher frequency and titers observed in NPSLE patients. The target antigens of these autoantibodies are still undetermined, but they likely include β2GPI.
FRONTIERS IN IMMUNOLOGY
(2023)